Mammography Vs Chemotherapy

The current recommendation is that women over the age of 40 should receive a mammogram every 1-2 years (Kidd, Colbert & Jatoi, 2015). Breast cancer mortality is higher in ethnic minorities including, Blacks, Hispanics, and Native Americans (O’Keefe, Meltzer, & Bethea, 2015). With Black, Hispanic, Asian, and White women with breast cancer in a low socioeconomic status, there is also an association with higher mortality rates (O’Keefe et al., 2015). The causes for these disparities is multifactorial and include knowledge deficit, incorrect perceptions about cancer, embarrassment, and prioritization of competing personal obligations, such as working or taking care of family members (Nonzee, et al., 2015). To add to the problem, minority women are much more likely to have high deductible insurance plans, or no insurance coverage at all (Tangka, et al., 2017). These issues lead to later stages of diagnosis of breast cancer, going longer between mammograms, lack of follow-up after suspicious findings on mammograms, and once diagnosed, incomplete treatment of breast cancer (O’Keefe et al.,

Breast cancer is a complex disease that will affect around 1 in 9 Canadian women during their lifespan. According to the latest statistics, it is found that around

Masson conducts a point in her article explaining that some women experience false positive mammograms and treated unnecessarily. She references from the Nordic Cochrane Centre information pamphlet that states “These women will have either a part of their breast or the whole breast removed, and they will often receive radiotherapy, and sometimes chemotherapy” (Masson, 2010). This can harvest a psychological strain on many women and cause increased distress and anxiety. Along with the emotional strain, direct financial costs to health services will be applied due to unnecessary procedures.

Many people think that having a yearly mammogram is a waste time and that it 's not a solution to breast cancer. One hundred thousand women turn into their 30s lives could be saved by annual screening. But others might not be safe those who turn forty. For every 1,000 women who have a mammogram screening only 100 of them are recalled to get more mammograms or ultrasound images, 20 of them are recommended for a needle biopsy, the other 5 are diagnosed with cancer. "About 40,290 women in the U.S. are expected to die in 2015 from breast cancer though death rates have been decreasing since 1989"("U.S. Breast Cancer...). The number of deaths was 21.9 per 100,00 women per year. These are the rates age-adjusted and based on 2008-2012 cases and

Mammography, the most effective method for detecting breast cancer at its early stages, can identify malignancies before they can be felt and before symptoms develop. According to the report, from 2000 to 2010, the percentage of women who received a mammogram decline for women from poor and low-income households and for non-Hispanic whites. Furthermore, women from poor, low-income, and middle-income households were less likely to receive a mammogram compared with women from high-income households. In National Healthcare Quality Report (NHQR), among women ages 50-64, uninsured women were less likely to receive a mammogram compared with those with private insurance. The two main factors that serve as a barrier to early detection and cure for breast cancer are socio-economic status (no health insurance/poor access to healthcare) and lack of awareness of the importance of breast cancer screening. The impact of these factors is to the patients and their families is that frequently, breast cancer would be detected at an already advanced stage and the prognosis would be poor, leading to mortality. Cancer diagnosed early before spread has occurred are generally more amenable to treatment and cancers diagnosed late with extensive spread have poor prognoses. In these cases, treatment would just be of palliative in nature. Early detection through screening means early treatment and lower mortality

In today’s society, women are not getting their mammograms done because they feel they are not necessary or because they are afraid of the results of the mammograms. Since women do not get their mammograms done, they are exposed to breast cancer. According to the National Cancer Institute, women who get mammograms, reduce about “15% to 20% in mortality from breast cancer” (“National Cancer Institute” 1). If women would increase the rate of getting mammograms, there will be less deaths in women.

Breast cancer is the second leading cause of death in women in the United States. A mammogram, is a simple test done with x-ray, to screen women for abnormalities of the breast. Over the past six years, the guidelines put out by various healthcare organizations have changed multiple times on when women should begin screening mammograms. Based on statistical data collected by the Kaiser Family Foundation (KFF), 20 percent of women go without a screening mammogram for their own various reasons, of which may be lack of insurance, lack of time or lack of knowledge as to when they should be getting a screening mammogram done due to the recent changes in recommendations. The utilization of annual screening mammograms beginning at age 40 will continue to help reduce the incidence rate of women with breast cancer, or catch it early enough so that treatment can be sought.

Breast cancer is the second most common cancer among women in the US. About 40,000 women die from breast cancer each year, making it “the second leading cause of cancer death among women” (Centers for Disease Control and Prevention, n.d.). The Patient Protection and Affordable Care Act (2010) requires insurers to “provide coverage for and shall not impose any cost sharing requirements for” preventive services which are “in the current recommendation of the United States Preventive Services Task Force” (USPSTF). Nevertheless, the ACA makes an exception for breast cancer screening by stating that the USPSTF’s recommendation regarding mammogram “shall be considered the most current other than those issued in or around November 2009”. By using this legislative tool, the federal government mandates health insurers to provide coverage for annual or biennial mammograms in women aged 40 and older (US Preventive Services Task Force, 2013).

The payments for this preventive care are different ranging from $60 to $70 for commercial insurance and $66.22 for Medicare. The payment is too low compared to other imaging procedures and do not include the fee for new technologies, such as digital and computer-assist detection. The Mammography Quality Standards Act (MQSA) adds extra financial burdens to mammography facilities by requiring that all facilities must satisfy the minimum standard for technologists, radiologists, physicists, and equipment. The requirements increase costs but does not increase reimbursement to cover those costs for healthcare facilities, which may become heavy burdens for small and low volume facilities (Nass, Henderson, & Lashof,

The Author reports that the new recommended age for mammograms, by the United States Preventative Services Task Force, has changed from 50 to 40 to reduce the harm from over screening and overtreatment. It also reports that self-breast examinations are no longer recommended on a regular basis. This recommendation comes from evidence that there are no major benefits of early screenings and that only “one cancer death is prevented for every 1,904 women” screened, age 40 to 49. Conversely, there is evidence that frequent early screenings can lead to overtreatment

The field of breast cancer treatment is in continual flux, and to keep “abreast” (pardon the pun) of the latest updates, consider attending our educational evening seminars, where local care providers offer the most up-to-date information. And read all you can; breast cancer is often in the news. As a way to filter the truth from hype in mass media, I highly recommend

Audience Link: There is a large amount of men and women who are diagnosed with breast cancer everyday but they usually don’t know how it forms and ways it can be treated. Breast cancer is a very serious disease that shouldn’t be taken likely. Even if you do not have breast cancer, chances are that you know or will

Immunotherapy for cancer treatment has had tremendous growth recently with increased awareness and knowledge of the immune system and potential means to manipulate it for therapeutic intent. Progress in the treatment of viral infections including CMV, EBV, HHV-6, utilization of immune checkpoint blockade for melanoma, non-small cell lung cancer, and Hodgkin Lymphoma, as well as rapid emergence of genetically modified T cells against CD19+ B cells have contributed to the growth in this area.Antibody-targeted therapy has now become standard of care for many malignancies, and the multi-domain utilization of antigen-specific adoptive T-cell therapy has shown great promises. 4 While our understanding of B cell and T cell and our ability to

As a result, the amount of money that gets propelled back into the healthcare industry skyrockets as the list of medical issues following these treatments grows more and more extensive. A study done by Dr. John Diamond shows that females who undergo chemotherapy and radiation treatments “face a 35% chance of developing breast cancer by the time they are 40, which is 75 times greater than average” (Dr. John Diamond, MD). Chemotherapy and radiation have been proven to weaken, and sometimes completely destroy, the immune system. This makes the already physically unstable patient even more susceptible to illnesses and diseases that they wouldn 't otherwise have had to worry about. Consequently, the recurrence of cancer is a very likely, and in some cases, unavoidable. But it is unacceptable that the most common and easily accessible drug is the reason why 35% of patients will develop a second cancer (haematologica.org). Many other cancers can come as a result of chemotherapy too. One study found that, "Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo

Through these screenings, prognosis improves when breast cancers are discovered in their earlier stages. Better access to health care for all citizens owing to Singapore’s economic growth and urban development too, allowed for earlier detection (Jara-Lazaro, Thilagaratnam, & Tan, 2010). Life expectancy of breast cancer patients hence have improved quite spectacularly with early detection and successful treatments that delayed cancer deaths (Beesley et al., 2008). This means that more people have lived with and survived breast cancer (Jara-Lazaro, et al., 2010).